HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BSE testing

This article was originally published in The Rose Sheet

Executive Summary

Grant applications for development of diagnostics to detect bovine spongiform encephalopathy in consumer products solicited by FDA in May 21 Federal Register. Research "will provide detection methodology critical to support food surveillance programs designed to keep BSE and other TSEs out of U.S. foods, cosmetics and dietary supplements," FDA says. Approximately $700,000 in FY 2001 funding will be available; agency will support "up to four awards of $100,000 to $200,000 (direct plus indirect costs) per award per year" for three years, notice states. Applications must be submitted by July 5. Under Bush Administration's proposed FY 2002 budget, FDA would receive roughly $18.8 mil. for BSE-related activities, with CFSAN receiving $1.1 mil. and five full-time equivalents (1"The Rose Sheet" April 16, p. 6)
Advertisement

Related Content

CFSAN FY 2002 Budget Proposes $1.1 Mil. For BSE Food, Cosmetics Review
CFSAN FY 2002 Budget Proposes $1.1 Mil. For BSE Food, Cosmetics Review
Advertisement
UsernamePublicRestriction

Register

RS009258

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel